| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.16 | 0.006 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.087 | 0.05 |